HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.

AbstractAIMS:
Impaired anti-inflammatory ability of high-density lipoprotein (HDL) has been demonstrated in patients with type-2 diabetes mellitus (T2DM). However, whether HDL from patients with diabetic nephropathy (DN) suffers additional damage remains unknown. This study compared the anti-inflammatory capacities of HDL from healthy controls, T2DM patients with normal renal function, and T2DM patients with DN.
MATERIALS AND METHODS:
HDL was isolated from healthy controls (n=33) and T2DM patients with normal renal function (n=21), chronic kidney disease (CKD) (n=27), and end-stage renal disease (ESRD) (n=27). Human peripheral blood mononuclear cells (PBMCs) from healthy volunteers were pretreated with HDL (100μg/mL) for 1h, then incubated with lipopolysaccharide (LPS) (50ng/mL) for 24h. The anti-inflammatory ability of HDL was measured as the secretion of TNF-α in LPS-activated monocytes.
RESULTS:
The anti-inflammatory ability of HDL was gradually impaired as kidney function declined. Serum amyloid A (SAA) concentration in HDLDN significantly increased and was positively correlated with the impaired anti-inflammatory ability of HDL (Pearson r=0.315, P=0.006). Furthermore, HDL supplemented with SAA significantly increased TNF-α release from PBMCs compared with that from control HDL.
CONCLUSIONS:
These findings identified an impaired anti-inflammatory capacity of HDL from DN patients, which might be attributable to SAA enrichment.
AuthorsJing Yan Mao, Jia Teng Sun, Ke Yang, Wei Feng Shen, Lin Lu, Rui Yan Zhang, Xuemei Tong, Yan Liu
JournalJournal of diabetes and its complications (J Diabetes Complications) Vol. 31 Issue 10 Pg. 1538-1543 (Oct 2017) ISSN: 1873-460X [Electronic] United States
PMID28760652 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier Inc. All rights reserved.
Chemical References
  • Lipopolysaccharides
  • Lipoproteins, HDL
  • Serum Amyloid A Protein
Topics
  • Adult
  • Aged
  • Cells, Cultured
  • China (epidemiology)
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 (complications)
  • Diabetic Angiopathies (epidemiology, immunology, metabolism, pathology)
  • Diabetic Nephropathies (immunology, metabolism, pathology, physiopathology)
  • Female
  • Hospitals, University
  • Humans
  • Kidney (physiopathology)
  • Kidney Failure, Chronic (complications, immunology, metabolism, pathology)
  • Leukocytes, Mononuclear (drug effects, immunology, metabolism, pathology)
  • Lipopolysaccharides (toxicity)
  • Lipoproteins, HDL (blood, isolation & purification, metabolism)
  • Male
  • Middle Aged
  • Outpatient Clinics, Hospital
  • Renal Insufficiency, Chronic (complications, immunology, metabolism, pathology)
  • Risk Factors
  • Serum Amyloid A Protein (analysis, metabolism)
  • Severity of Illness Index
  • Vasculitis (complications, immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: